Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Aug 15, 2021; 13(8): 929-942
Published online Aug 15, 2021. doi: 10.4251/wjgo.v13.i8.929
Published online Aug 15, 2021. doi: 10.4251/wjgo.v13.i8.929
Figure 2 Spleen density of intrahepatic cholangiocarcinoma patients.
A-C: Mean spleen density at the upper pole level (A), hilum level (B), and inferior pole level (C) on computed tomography; D: Optimal cut-off level of spleen density that stratified patients into diffuse reduction of spleen density (DROSD) and non-DROSD subgroups was 45.5 Hounsfield units.
- Citation: Deng LM, Wang Y, Yang JH, Li JL, Chen ZY, Bao WM, Chen KY, Yao XF, Zheng CM, Zheng JY, Yu ZP, Jin B, Chen G. Diffuse reduction of spleen density is a novel prognostic marker for intrahepatic cholangiocarcinoma after curative resection. World J Gastrointest Oncol 2021; 13(8): 929-942
- URL: https://www.wjgnet.com/1948-5204/full/v13/i8/929.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i8.929